TPG Said to Weigh Pathology Asia Stake Sale Ahead of IPO

Private equity firm TPG Capital Asia is exploring selling a stake in its pathology business in the region ahead of a potential initial public offering for the unit, according to people with knowledge of the matter.

The buyout firm could sell a 20% stake in Pathology Asia Holdings Pte and is working with advisers on the potential divestment, said the people, who asked not to be identified as the process is private. A deal for the medical unit, which is valued at about $2 billion, could come as early as January, the people said.

Deliberations are ongoing and there is ...